A detailed history of Patten Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Patten Group, Inc. holds 16,387 shares of NVS stock, worth $1.59 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
16,387
Previous 16,513 0.76%
Holding current value
$1.59 Million
Previous $1.76 Million 7.23%
% of portfolio
0.43%
Previous 0.42%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$106.13 - $120.89 $13,372 - $15,232
-126 Reduced 0.76%
16,387 $1.88 Million
Q2 2024

Jul 25, 2024

BUY
$92.57 - $107.37 $37,305 - $43,270
403 Added 2.5%
16,513 $1.76 Million
Q4 2023

Jan 10, 2024

BUY
$92.27 - $101.54 $27,588 - $30,360
299 Added 1.89%
16,110 $1.63 Million
Q3 2023

Oct 12, 2023

BUY
$94.73 - $105.13 $1,799 - $1,997
19 Added 0.12%
15,811 $1.61 Million
Q1 2023

Apr 06, 2023

BUY
$80.03 - $92.81 $9,443 - $10,951
118 Added 0.75%
15,792 $1.45 Million
Q4 2022

Feb 10, 2023

BUY
$75.55 - $92.52 $35,130 - $43,021
465 Added 3.06%
15,674 $1.42 Million
Q2 2022

Jul 18, 2022

BUY
$80.52 - $93.75 $724 - $843
9 Added 0.06%
15,209 $1.28 Million
Q1 2022

Apr 28, 2022

BUY
$80.11 - $90.62 $63,367 - $71,680
791 Added 5.49%
15,200 $1.33 Million
Q4 2021

Jan 20, 2022

BUY
$79.7 - $88.13 $3,825 - $4,230
48 Added 0.33%
14,409 $1.26 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $4,906 - $5,708
-60 Reduced 0.42%
14,361 $1.17 Million
Q2 2021

Aug 03, 2021

SELL
$85.24 - $94.15 $100,242 - $110,720
-1,176 Reduced 7.54%
14,421 $1.32 Million
Q1 2021

Apr 23, 2021

BUY
$83.5 - $98.47 $2,254 - $2,658
27 Added 0.17%
15,597 $1.33 Million
Q4 2020

Feb 02, 2021

SELL
$78.07 - $94.43 $17,956 - $21,718
-230 Reduced 1.46%
15,570 $1.47 Million
Q3 2020

Oct 19, 2020

BUY
$82.14 - $91.0 $4,517 - $5,005
55 Added 0.35%
15,800 $1.37 Million
Q2 2020

Jul 20, 2020

SELL
$80.93 - $91.1 $38,279 - $43,090
-473 Reduced 2.92%
15,745 $1.38 Million
Q1 2020

Apr 16, 2020

SELL
$70.67 - $99.01 $79,857 - $111,881
-1,130 Reduced 6.51%
16,218 $1.34 Million
Q4 2019

Jan 14, 2020

SELL
$84.35 - $95.37 $9,025 - $10,204
-107 Reduced 0.61%
17,348 $1.64 Million
Q3 2019

Oct 22, 2019

SELL
$85.54 - $94.26 $7,270 - $8,012
-85 Reduced 0.48%
17,455 $1.52 Million
Q2 2019

Jul 11, 2019

BUY
$75.4 - $92.8 $16,663 - $20,508
221 Added 1.28%
17,540 $1.6 Million
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $16,796 - $19,211
223 Added 1.3%
17,319 $1.67 Million
Q4 2018

Feb 12, 2019

SELL
$73.66 - $82.02 $58,486 - $65,123
-794 Reduced 4.44%
17,096 $1.47 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $44,180 - $51,103
-660 Reduced 3.56%
17,890 $1.54 Million
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $55,238 - $62,429
-851 Reduced 4.39%
18,550 $1.4 Million
Q1 2018

May 11, 2018

SELL
$70.39 - $84.15 $6,757 - $8,078
-96 Reduced 0.49%
19,401 $1.57 Million
Q4 2017

Feb 02, 2018

SELL
$72.33 - $77.64 $39,130 - $42,003
-541 Reduced 2.7%
19,497 $1.64 Million
Q3 2017

Dec 13, 2017

SELL
$74.14 - $77.27 $2.95 Million - $3.08 Million
-39,844 Reduced 66.54%
20,038 $1.72 Million
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $2.95 Million - $3.08 Million
39,844 Added 198.84%
59,882 $1.72 Million
Q2 2017

Aug 14, 2017

BUY
N/A
20,038
20,038 $1.7 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Patten Group, Inc. Portfolio

Follow Patten Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.